NYSE$DNMRQ
Danimer Scientific Inc. · Q3 2023 earnings
Q3 2023 earnings · · Investor relations
Briefing
PHA-Based Product Revenue Grew 58% vs. Prior Year
Danimer Scientific reported revenue growth, driven by PHA-based products, but experienced a gross profit decline due to increased production costs. The company has reduced its full-year adjusted EBITDA guidance due to delays in customer launches and first shipments.
- Revenues in the third quarter grew to $10.9 million compared to $10.4 million in the year-ago quarter.
- Gross profit in the third quarter was $(7.7) million compared to $(4.1) million in the third quarter of 2022.
- Third quarter net loss was $(40.2) million this year compared to a net loss of $(94.9) million last year.
- Adjusted EBITDA was $(9.3) million in the third quarter of 2023 compared to $(12.9) million in the third quarter of 2022.
Headline financials
Revenue & EPS history
Danimer Scientific · Revenue · Quarterly
$10.9M
Revenue by segment
Danimer Scientific · $10.9M total across 2 segments · Q3 2023
- Products$10.5M—95.5%
- Services$494K—4.5%
Forward guidance
The Company has modified its full-year 2023 adjusted EBITDA guidance to a range of $(40) million to $(37) million and now anticipates full-year capital expenditures in the range of $27 million to $29 million.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 11 quarterly earnings reports · overlaid with Q3 2023
+1.1%
Avg return
Earnings day
+2.4%
Avg return
5 days after
-19.1%
Avg return
30 days after
58%
11 / 19 earnings
Positive
+26.3%
Q1 2023
Best reaction
-29.0%
Q3 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2024 | +0.0% | +0.0% | +0.0% | |
| Q3 2024 | -29.0% | -36.3% | -69.3% | |
| Q2 2024 | -0.9% | -7.1% | -27.9% | |
| Q1 2024 | -3.7% | -1.9% | -28.2% | |
| Q4 2023 | +2.0% | -10.7% | -38.0% | |
| Q3 2023 | +2.0% | -2.8% | -16.7% | |
| Q2 2023 | -6.4% | -14.2% | -24.4% | |
| Q1 2023 | +26.3% | +27.0% | +3.1% | |
| Q4 2022 | +9.3% | +28.2% | +17.1% | |
| Q3 2022 | +3.7% | +23.2% | -14.9% | |
| Q2 2022 | +4.3% | +21.3% | -11.2% | |
| Q1 2022 | -3.6% | — | — | |
| Q4 2021 | +21.1% | — | — | |
| Q3 2021 | -18.0% | — | — | |
| Q2 2021 | -2.9% | — | — | |
| Q1 2021 | +12.0% | — | — | |
| Q4 2020 | +2.5% | — | — | |
| Q2 2020 | +2.5% | — | — | |
| Q3 2020 | +0.3% | — | — | |
| Q1 2020 | — | — | — | |
| Q4 2019 | — | — | — | |
| Q3 2019 | — | — | — | |
| Q2 2019 | — | — | — | |
| Q1 2019 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro